Chemoinformaics analysis of GALLIC-ACID-ETHYL-ESTER
| Molecular Weight | 230.216 | nRot | 3 |
| Heavy Atom Molecular Weight | 216.104 | nRig | 7 |
| Exact Molecular Weight | 230.079 | nRing | 1 |
| Solubility: LogS | -1.867 | nHRing | 0 |
| Solubility: LogP | 2.042 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 30.8471 |
| nHD | 3 | BPOL | 14.9129 |
| QED | 0.52 |
| Synth | 2.118 |
| Natural Product Likeliness | 0.462 |
| NR-PPAR-gamma | 0.781 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.002 |
| HIA | 0.025 |
| CACO-2 | -4.801 |
| MDCK | 0.0000147 |
| BBB | 0.104 |
| PPB | 0.921351 |
| VDSS | 0.397 |
| FU | 0.0661118 |
| CYP1A2-inh | 0.85 |
| CYP1A2-sub | 0.348 |
| CYP2c19-inh | 0.072 |
| CYP2c19-sub | 0.059 |
| CYP2c9-inh | 0.303 |
| CYP2c9-sub | 0.442 |
| CYP2d6-inh | 0.283 |
| CYP2d6-sub | 0.218 |
| CYP3a4-inh | 0.165 |
| CYP3a4-sub | 0.125 |
| CL | 17.557 |
| T12 | 0.934 |
| hERG | 0.039 |
| Ames | 0.148 |
| ROA | 0.006 |
| SkinSen | 0.933 |
| Carcinogencity | 0.034 |
| EI | 0.954 |
| Respiratory | 0.103 |
| NR-Aromatase | 0.149 |
| Antiviral | No |
| Prediction | 0.891098 |